Inhaled Dual Phosphodiesterase 3/4 Inhibitors for the Treatment of Patients with COPD: A Short Review

Inhaled Dual Phosphodiesterase 3/4 Inhibitors for the Treatment of Patients with COPD: A Short Review

Clémence Martin,1,2 Pierre-Régis Burgel,1,2 Nicolas Roche1,2 1AP-HP Centre, Hôpital Cochin, Service de Pneumologie, Paris, France; 2Université de Paris, Institut Cochin, INSERM UMR 1016, Paris, FranceCorrespondence: Nicolas RocheService de Pneumologie, Hôpital Cochin, 27 rue du Faubourg Saint Jacque...

Full description

Bibliographic Details
Main Authors: Martin C, Burgel PR, Roche N
Format: Article
Language:English
Published: Dove Medical Press 2021-08-01
Series:International Journal of COPD
Subjects:
copd
phosphodiesterase inhibitors
bronchodilation
inflammation
mucus
epithelium
Online Access:https://www.dovepress.com/inhaled-dual-phosphodiesterase-34-inhibitors-for-the-treatment-of-pati-peer-reviewed-fulltext-article-COPD

Internet

https://www.dovepress.com/inhaled-dual-phosphodiesterase-34-inhibitors-for-the-treatment-of-pati-peer-reviewed-fulltext-article-COPD

Similar Items